You dont owe anyone an explanation. If youre comfortable discussing your health, Bansal recommends being honest about how you feel
And the third reason is that there are so many
Key Points Summary Asias GLP1 uptake has lagged the West but is primed for rapid acceleration as obesity rates rise and government urgency grows China and India are driving demand shifts as diets westernise and metabolic disease climbs Cost barriers are falling: local firms in China and India are developing cheaper semaglutide generics, forcing price cuts Mintel forecasts explosive growth, with China potentially becoming the worlds No1 GLP1 market by 2030 Safety fears persist in China (side effects, rebound, semaglutide face) and in India (strict rules on drug promotion) GLP-1 agonist drugs have revolutionised weight loss in the United States and parts of Europe, providing in most cases a highly effective way to manage the ballooning issue of obesity in these markets
Theyve helped me on my weight-loss journey over a period of time and have been there offering support throughout, with regular catch-up sessions to check how things are going
Patients with certain FTO variants, for example, may benefit from additional metabolic support, while GIPR variants can guide how aggressively your body responds to semaglutide dosing and nutrient absorption patterns